ArticleThoracic cancer2019

Value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non-predominant lung adenocarcinoma.

Shuhui Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.